Product
pA1c®HI a Postbiotic ingredient for glucose metabolic health
Top 10 Nutritional Supplements Trends in 2023. pA1c®HI for the nutritional management of blood glucose levels.
CoFounder & CEO
Genbioma Aplicaciones S.L.
Navarra, Navarra, Spain
Genbioma: Microbiome Science for Metabolic Disorders: Postbiotics for Diabetes & Obesity and cardiometabolic.
Co-Founder, Investor and Managing Director at Genbioma.
Ph.D. in Food Sci and Tech, MSc Degree on Food Sci. & Tech and BSc Degree on Nutrition and Human Health.
Top 60 Women in AgriFood 2024 . EIC Women Leadership Programme 2023. +25 year in Healthy Foods Sector focused on international market. Member of National and European Technical Committees in Food&Health.Co-author of 30 scientific articles, 6 international patents +50 R&D projects +50 Conferences. h-index: 14
GENBIOMA: Probiota Pioneers 2022. Top 10 Global Nutritional Supplements Trends 2023. Top 10 International Next Wave of Startups of Microbiome Technology (2023).Top 101 Spanish startups (2024).
Microbiome Science for metabolic disorders in human health. Postbiotics (Microbiome based Products) for Diabetes related conditions (PreDiabetes, T2Diabetes) & Obesity. Solid scientific research on the Mechanism of Action. Metabolism & Gut Microbiota. Personalized and precision Microbiome-based products (Postbiotics) for the nutritional management of metabolic disorders. Focused on international market.
My organisation
Skills
Interests
Product
pA1c®HI a Postbiotic ingredient for glucose metabolic health
Top 10 Nutritional Supplements Trends in 2023. pA1c®HI for the nutritional management of blood glucose levels.
Product
POSTBIOTIC nutritional supplement for glucose control: Reglubetic(R)HI
Reglubetic®HI is a food supplement for glucose metabolic disorders (Diabetes). Affordable and industrially scaled up. Open to market.